Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Maastricht University Medical Center Top Institute Food and Nutrition |
---|---|
Information provided by: | Maastricht University Medical Center |
ClinicalTrials.gov Identifier: | NCT00643773 |
The purpose of this study is to determine whether long term leucine supplementation has a positive effect on body composition and muscle characteristics in elderly, type 2 diabetes patients.
Condition | Intervention | Phase |
---|---|---|
Type 2 Diabetes |
Dietary Supplement: Leucine Dietary Supplement: Wheat flour |
Phase II Phase III |
Study Type: | Interventional |
Study Design: | Randomized, Double Blind (Subject, Caregiver), Factorial Assignment, Efficacy Study |
Official Title: | The Influence of Leucine Supplementation on Body Composition and Muscle Characteristics in Elderly, Type 2 Diabetes Patients. |
Estimated Enrollment: | 60 |
Study Start Date: | May 2008 |
Estimated Primary Completion Date: | November 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
A: Experimental
Leucine supplement
|
Dietary Supplement: Leucine
capsules are 0.5g, subjects take 5 capsules with every main meal for 6 months In total this is 15 capsules per day
|
B: Placebo Comparator
Wheat flour
|
Dietary Supplement: Wheat flour
Wheat flour
|
Ages Eligible for Study: | 65 Years and older |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Marika Leenders, MSc | 043 3881394 ext +31 | Marika.Leenders@BW.unimaas.nl |
Contact: Luc JC van Loon, PhD | 043 3881397 ext +31 | L.vanLoon@hb.unimaas.nl |
Netherlands | |
Maastricht University | Recruiting |
Maastricht, Netherlands, 6229 ER | |
Contact: Marika Leenders, MSc +31433881394 Marika.Leenders@BW.unimaas.nl | |
Principal Investigator: Marika Leenders, MSc |
Principal Investigator: | Marika Leenders, MSc | Maastricht University Medical Center |
Responsible Party: | Maastricht University ( MSc Marika Leenders ) |
Study ID Numbers: | MEC-07-1111 |
Study First Received: | March 20, 2008 |
Last Updated: | February 3, 2009 |
ClinicalTrials.gov Identifier: | NCT00643773 History of Changes |
Health Authority: | Netherlands: The Central Committee on Research Involving Human Subjects (CCMO) |
Elderly |
Metabolic Diseases Diabetes Mellitus, Type 2 Diabetes Mellitus Endocrine System Diseases |
Endocrinopathy Glucose Metabolism Disorders Metabolic Disorder |
Metabolic Diseases Diabetes Mellitus, Type 2 Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders |